260 Novel CLL-1-directed CAR-T cells mediate potent antigen-specific cytolytic activity in mouse models of acute myeloid leukemia
Main Authors: | Mariana Silva, Brikena Gjeci, Julian Scherer, Reid Williams, Hillary Hoyt, Amanda Halfond, Giacomo Canesin, Julia Etchin, Guy Mundelboim, John Lydeard, Tirtha Chakraborty |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2023-11-01
|
Series: | Journal for ImmunoTherapy of Cancer |
Similar Items
-
P1429: MULTIPLEX DELETION OF MYELOID ANTIGENS CD33 AND CLL-1 BY CRISPR/CAS9 IN HUMAN HEMATOPOIETIC STEM CELLS HIGHLIGHTS THE POTENTIAL OF NEXT-GENERATION TRANSPLANTS FOR AML TREATMENT.
by: J. Xavier-Ferrucio, et al.
Published: (2022-06-01) -
Development of a gene edited next-generation hematopoietic cell transplant to enable acute myeloid leukemia treatment by solving off-tumor toxicity
by: John R. Lydeard, et al.
Published: (2023-12-01) -
CAR-T cells targeting CLL-1 as an approach to treat acute myeloid leukemia
by: Jinghua Wang, et al.
Published: (2018-01-01) -
Successful Anti-CLL1 CAR T-Cell Therapy in Secondary Acute Myeloid Leukemia
by: Hui Zhang, et al.
Published: (2020-05-01) -
The Transcriptome of Rhabdomyosarcoma Cells Infected with Cytolytic and Non-Cytolytic Variants of Coxsackievirus B2 Ohio-1.
by: Anna Sävneby, et al.
Published: (2016-01-01)